The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: Reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion
Samantha E. Yohn, Christian Thompson, Patrick A. Randall, Christie A. Lee, Christa E. Müller, Younis Baqi, Mercè Correa, John D. Salamone*
*المؤلف المقابل لهذا العمل
نتاج البحث: المساهمة في مجلة › Article › مراجعة النظراء
75
اقتباسات
(Scopus)